
Sign up to save your podcasts
Or
Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
3.8
6161 ratings
Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
3,877 Listeners
1,461 Listeners
38,202 Listeners
6,663 Listeners
8,864 Listeners
139 Listeners
2,062 Listeners
111,261 Listeners
2,272 Listeners
1,465 Listeners
12,632 Listeners
302 Listeners
6,739 Listeners
469 Listeners
52 Listeners
2,298 Listeners
380 Listeners
1,448 Listeners
6,668 Listeners
5,412 Listeners
15,256 Listeners
1,497 Listeners
1,438 Listeners
7 Listeners
3,295 Listeners
20 Listeners
9 Listeners
1,067 Listeners
408 Listeners
0 Listeners
36 Listeners